MRI and CT imaging for preoperative target volume delineation in breast-conserving therapy

BackgroundAccurate tumor bed delineation after breast-conserving surgery is important. However, consistency among observers on standard postoperative radiotherapy planning CT is low and volumes can be large due to seroma formation. A preoperative delineation of the tumor might be more consistent. Therefore, the purpose of this study was to determine the consistency of preoperative target volume delineation on CT and MRI for breast-conserving radiotherapy.MethodsTumors were delineated on preoperative contrast-enhanced (CE) CT and newly developed 3D CE-MR images, by four breast radiation oncologists. Clinical target volumes (CTVs) were created by addition of a 1.5 cm margin around the tumor, excluding skin and chest wall. Consistency in target volume delineation was expressed by the interobserver variability. Therefore, the conformity index (CI), center of mass distance (dCOM) and volumes were calculated. Tumor characteristics on CT and MRI were scored by an experienced breast radiologist.ResultsPreoperative tumor delineation resulted in a high interobserver agreement with a high median CI for the CTV, for both CT (0.80) and MRI (0.84). The tumor was missed on CT in 2/14 patients (14%). Leaving these 2 patients out of the analysis, CI was higher on MRI compared to CT for the GTV (p < 0.001) while not for the CTV (CT (0.82) versus MRI (0.84), p = 0.123). The dCOM did not differ between CT and MRI. The median CTV was 48 cm3 (range 28–137 cm3) on CT and 59 cm3 (range 30–153 cm3) on MRI (p < 0.001). Tumor shapes and margins were rated as more irregular and spiculated on CE-MRI.ConclusionsThis study showed that preoperative target volume delineation resulted in small target volumes with a high consistency among observers. MRI appeared to be necessary for tumor detection and the visualization of irregularities and spiculations. Regarding the tumor delineation itself, no clinically relevant differences in interobserver variability were observed. These results will be used to study the potential for future MRI-guided and neoadjuvant radiotherapy.Trial registrationInternational Clinical Trials Registry Platform NTR3198.

[1]  P. Bondiau,et al.  Phase 1 clinical trial of stereotactic body radiation therapy concomitant with neoadjuvant chemotherapy for breast cancer. , 2013, International journal of radiation oncology, biology, physics.

[2]  L. Kim,et al.  What is the target volume for preoperative accelerated partial breast irradiation (APBI)? In regards to Nichols et al. (Int J Radiat Oncol Biol Phys 2010;77:197-202) and Palta et al. (Int J Radiat Oncol Biol Phys 2010, in Press). , 2011, International journal of radiation oncology, biology, physics.

[3]  Eric Berthelet,et al.  Target volume delineation for partial breast radiotherapy planning: clinical characteristics associated with low interobserver concordance. , 2007, International journal of radiation oncology, biology, physics.

[4]  B. van Asselen,et al.  Changes in excision cavity volume: prediction of the reduction in absolute volume during breast irradiation. , 2007, International journal of radiation oncology, biology, physics.

[5]  Michel Bolla,et al.  Predictors of the risk of fibrosis at 10 years after breast conserving therapy for early breast cancer: a study based on the EORTC Trial 22881-10882 'boost versus no boost'. , 2008, European journal of cancer.

[6]  H. Bartelink,et al.  Impact of a higher radiation dose on local control and survival in breast-conserving therapy of early breast cancer: 10-year results of the randomized boost versus no boost EORTC 22881-10882 trial. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  Anil Sethi,et al.  Breast boost: Are we missing the target? , 2003, Cancer.

[8]  Corine van Vliet-Vroegindeweij,et al.  Multiinstitutional study on target volume delineation variation in breast radiotherapy in the presence of guidelines. , 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[9]  Karel G M Moons,et al.  Meta-analysis of MR imaging in the diagnosis of breast lesions. , 2008, Radiology.

[10]  W. Mali,et al.  Excised and irradiated volumes in relation to the tumor size in breast-conserving therapy , 2011, Breast Cancer Research and Treatment.

[11]  C. Raaijmakers,et al.  Interobserver variability of clinical target volume delineation of glandular breast tissue and of boost volume in tangential breast irradiation. , 2005, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[12]  N. Moriyama,et al.  Diagnosis of breast cancer with multidetector computed tomography: analysis of optimal delay time after contrast media injection. , 2010, Clinical imaging.

[13]  R Peto,et al.  Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10 801 women in 17 randomised trials , 2011, The Lancet.

[14]  Marjan Admiraal,et al.  Significance of breast boost volume changes during radiotherapy in relation to current clinical interobserver variations. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[15]  L Collette,et al.  The influence of patient, tumor and treatment factors on the cosmetic results after breast-conserving therapy in the EORTC 'boost vs. no boost' trial. EORTC Radiotherapy and Breast Cancer Cooperative Groups. , 2000, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[16]  T. Whelan,et al.  Altered fractionation: rationale and justification for whole and partial breast hypofractionated radiotherapy. , 2011, Seminars in radiation oncology.

[17]  W. Kaiser,et al.  Development, standardization, and testing of a lexicon for reporting contrast‐enhanced breast magnetic resonance imaging studies , 2001, Journal of magnetic resonance imaging : JMRI.

[18]  Roland Holland,et al.  Precise correlation between MRI and histopathology - exploring treatment margins for MRI-guided localized breast cancer therapy. , 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[19]  Erik Kouwenhoven,et al.  MRI- versus CT-based volume delineation of lumpectomy cavity in supine position in breast-conserving therapy: an exploratory study. , 2012, International journal of radiation oncology, biology, physics.

[20]  L. Boersma,et al.  PO-0625 EXTERNAL BEAM PARTIAL BREAST IRRADIATION: DIFFERENCE IN PRE-AND POSTOPERATIVE TARGET VOLUME DELINEATION , 2012 .

[21]  S. Feigenberg,et al.  Preoperative Radiation Therapy Significantly Increases Patient Eligibility for Accelerated Partial Breast Irradiation Using 3D-conformal Radiotherapy , 2013, American journal of clinical oncology.

[22]  Jan J W Lagendijk,et al.  MR-guided breast radiotherapy: feasibility and magnetic-field impact on skin dose , 2013, Physics in medicine and biology.

[23]  Uulke A. van der Heide,et al.  Simultaneous multi-modality ROI delineation in clinical practice , 2009, Comput. Methods Programs Biomed..

[24]  Jan J W Lagendijk,et al.  MRI/linac integration. , 2008, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[25]  E. Rakovitch,et al.  Tolerance and acceptance results of a palladium-103 permanent breast seed implant Phase I/II study. , 2009, International journal of radiation oncology, biology, physics.

[26]  E. Rutgers,et al.  On the feasibility of MRI-guided navigation to demarcate breast cancer for breast-conserving surgery. , 2010, Medical physics.

[27]  Tomas Janssen,et al.  Reducing interobserver variation of boost-CTV delineation in breast conserving radiation therapy using a pre-operative CT and delineation guidelines. , 2012, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[28]  I. Trop,et al.  Localization of the surgical bed using supine magnetic resonance and computed tomography scan fusion for planification of breast interstitial brachytherapy. , 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[29]  S. Yoo,et al.  Preoperative single fraction partial breast radiotherapy for early-stage breast cancer. , 2012, International journal of radiation oncology, biology, physics.

[30]  R Jena,et al.  Titanium clip placement to allow accurate tumour bed localisation following breast conserving surgery: audit on behalf of the IMPORT Trial Management Group. , 2008, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[31]  J. Bellon,et al.  Variability among breast radiation oncologists in delineation of the postsurgical lumpectomy cavity. , 2007, International journal of radiation oncology, biology, physics.

[32]  E. Kouwenhoven,et al.  Measuring the similarity of target volume delineations independent of the number of observers , 2009, Physics in medicine and biology.

[33]  Early Breast Canc Trialists Collab.  Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10 801 women in 17 randomised trials , 2011 .